FOSUN HEALTH Logo

Lupus Nephritis Overview

catalogue

Lupus Nephritis Overview

Lupus Nephritis Overview

Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, and the first thing to understand about it is that the kidney has not caught anything on its own. Antibodies bind the body's own nuclear material, the resulting immune complexes settle in the filtering units, and inflammation follows. That single fact explains the whole shape of the care: the kidney is treated by treating the immune system, the rest of the body is assessed at the same time, and a kidney biopsy is standard rather than exceptional because what the microscope shows is what the treatment is chosen from. This guide follows the path patients actually walk — what moves before anything is felt, how the class is read, why treatment comes in two phases, and what living with the result actually involves.

Lupus Nephritis Overview
  • the class under the microscope decides how strong the treatment has to be

  • months of induction to stop the inflammation, then years of maintenance to hold it

  • urine sediment, complement and anti-dsDNA usually move before anything is felt

  • the year our nephrology department was established

What lupus nephritis is — a whole-body illness reaching the filter

Systemic lupus erythematosus is a disease in which the immune system makes antibodies against the body's own nuclear material — DNA, RNA and the proteins that package them. Those antibodies bind their targets and form immune complexes that circulate in the blood. Some of them end up in the kidney, because the kidney filters an enormous volume of blood and its filtering units are built to trap material out of it. Once deposited, the complexes activate complement, and complement calls in inflammation. The result is glomerulonephritis: inflammation of the filtering units, which leak protein and blood while it is active and scar over once it has been.

Whether the kidney is involved, and how severely, is the single strongest determinant of how lupus affects a person's long-term health. That is not a statement meant to frighten. It is the reason the kidney is looked for so persistently — and the reason that finding it early, while the inflammation is still active rather than scarred, changes what the rest of a life looks like.

Three things follow from the mechanism, and they shape every page in this guide. First, this is not a kidney disease that happens to occur in people with lupus: it is lupus, in the kidney. Treatment is aimed at the immune system, and a flare elsewhere in the body — a rash, painful joints, pleurisy, a falling blood count — matters to the kidney as much as the urine does. Second, what is active and what is scarred are different things. Active inflammation can be quietened; scar tissue cannot, and treating scar with immunosuppression adds risk without benefit. Third, the disease is measured, not felt. The tests move first, sometimes weeks before a person notices anything, which is why the monitoring schedule exists and why it is kept to even when life is going well.

The six classes, and why the class is what the treatment is chosen from

Lupus nephritis is classified by what a pathologist sees on the biopsy, using the classification agreed by the International Society of Nephrology and the Renal Pathology Society. The class is not a score or a ranking of how unwell someone is — it is a description of the pattern of injury, and different patterns call for different intensities of treatment.

The six classes, and what each one usually means for treatment
Class What the biopsy shows What it usually means
Class I — minimal mesangial Deposits visible only on immunofluorescence or electron microscopy; the kidney looks normal under the ordinary microscope Generally managed by treating the lupus rather than the kidney, with monitoring
Class II — mesangial proliferative Increased cells and deposits confined to the mesangium, the scaffolding at the centre of the filtering tuft Usually mild. Kidney-directed immunosuppression is often not needed; blood pressure, protein and lupus control are
Class III — focal Inflammation in a minority of the filtering units, with active lesions, scarring, or both Requires induction treatment. The proportion of active versus scarred lesions decides how far to go
Class IV — diffuse Inflammation involving half or more of the filtering units, in a segment of each or throughout them The class most likely to threaten the kidney, and the one treated most actively. Also the one where treatment has the most to gain
Class V — membranous Thickened capillary walls from deposits on the outer side, often with heavy protein loss and a nephrotic picture; it can occur together with class III or IV Protein loss dominates the picture. Whether immunosuppression is needed depends on how much protein is being lost and whether a proliferative class is present alongside it
Class VI — advanced sclerosing Most filtering units already replaced by scar Immunosuppression is generally not the answer here, and may do harm. Care turns to protecting the function that remains and planning replacement

Two qualifications matter more than the class itself. The first is that the class carries a second reading alongside it — how much of what is present is active and how much is chronic — and it is that balance, more than the class number, that decides how hard to treat. The second is that the class is not fixed for life: it can change between biopsies, and a person whose disease behaves differently on a second look is re-evaluated rather than continued on the previous plan by default. Both are set out on the diagnosis page.

How it is tracked: activity, chronicity and the two treatment phases

Lupus nephritis is not staged by a single number. It is followed along two things at once: what the disease is doing now, and how much permanent change it has already left behind. Keeping those separate is what stops both errors — treating scar as if it were inflammation, and failing to treat inflammation because the damage already present looks discouraging.

What is being tracked, and what each state calls for
State What the tests show What it calls for
Active inflammation Cells and casts in the urine sediment, protein rising, filtration falling over weeks, complement falling, anti-dsDNA rising Induction treatment, aimed at stopping the inflammation while it is still inflammation
Partial response Protein falling, sediment quietening, filtration stabilising — improvement that has not yet reached the target Treatment continued, with the plan and the target restated rather than quietly extended
Complete response Urine close to normal, filtration stable, blood tests settled Maintenance, at the lowest dose that holds it — held for years, not months
Flare The activity returning after a period of quiet, often first in the blood tests Reassessment rather than reflex: how much is active, and whether a repeat biopsy would change the plan
Chronic damage predominating Residual protein with a quiet sediment, filtration drifting down slowly, no signs of activity Immunosuppression steps back; protecting the remaining function takes over
Kidney failure Filtration far reduced, with the complications of reduced filtration dominating Replacement therapy and transplantation planned years ahead, and timed to a period of quiet disease

The row that catches people out is the third one. A complete response is the goal, and it is genuinely good news, but it is not the same as the disease being over: maintenance continues for years afterwards, because stopping early is one of the commonest ways a remission is lost. What the maintenance period actually involves, and how it is eventually stepped down, is described on the treatment page and the living-with-it page.

What a full assessment contains

An assessment has two jobs that are often confused: establishing whether the kidney is involved at all, and establishing what is happening in it well enough to choose a treatment. The second job needs the biopsy. Everything else is what tells you when to ask, and what to measure afterwards.

Each test and the question it answers
Test The question it answers
Urine microscopy Is inflammation active right now? Red cells, white cells and cellular casts are the most direct answer available
Protein, measured quantitatively How much is being lost — as a spot protein-to-creatinine ratio or a timed collection. This is the number the response is judged against
Creatinine and filtration rate, repeated How much function is left, and is it falling over weeks rather than years?
Complement C3 and C4 Is immune activity consuming complement? Low levels are one of the earliest signals of a flare
Anti-dsDNA antibodies Is antibody production rising? It tracks activity in many people, though not perfectly in all
Antinuclear, anti-Smith and antiphospholipid antibodies Is this lupus, and is there an added clotting risk that changes the plan?
Albumin and lipids Has protein loss reached a nephrotic pattern? This affects both treatment and clotting risk
Kidney biopsy, with immunofluorescence and electron microscopy Which class is this, how much is active, how much is scarred? The question everything else is arranged around
Screening for latent infection before immunosuppression Is there something that would flare if the immune system were dampened? Asked before treatment, not after

What matters about the two antibody and complement tests is that they are not a verdict, they are a trend. A single value is a reading; a series kept over months is a pattern, and the pattern is what a clinician acts on. That is also why the monitoring page asks you to keep your own dated record — a pattern reconstructed from memory is not a pattern.

Why patients come to China for lupus nephritis

Our nephrology department was established in 2004 and is the leading unit of the Fosun Health nephrology alliance. It runs 20 specialised beds, more than 30 haemodialysis machines and two continuous renal replacement therapy machines, and it sees close to 20,000 kidney outpatient visits and close to 1,000 inpatient admissions a year. The department performs kidney biopsy with immunofluorescence and electron microscopy, establishes and maintains vascular access, places peritoneal dialysis catheters, and provides double plasma exchange and hybrid blood purification. It works alongside rheumatology colleagues in planning and following immunosuppressive treatment, and it is supported by a dedicated kidney disease clinic in the traditional Chinese medicine department.

What international patients mostly come for is not a medicine unavailable at home. It is the assembly: a biopsy read for class, activity and chronicity rather than described in a line; the lupus assessed as a whole-body disease at the same time, with the kidney and the rest of the body in one plan rather than two; every medicine reviewed for its effect on the kidney and on the immune system; and a written schedule with dates and targets that a local team can continue. Those steps are described on the diagnosis page and the treatment page.

The first of them happens before any travel is discussed. Sending your records — urine results with dates, protein measurements, creatinine and filtration readings, complement and anti-dsDNA results if you have them, any biopsy report, and your full medicine list — lets a clinician tell you whether anything is missing and what can be established where you are. The practical questions page sets out what to send and what a first visit actually involves.

Frequently Asked Questions

Will I feel it when lupus starts affecting my kidneys?

Often not, and that is the reason lupus is monitored with tests rather than with questions about how you feel. Early kidney involvement produces no pain and no visible change in urine. What moves first is on paper: red cells and casts appearing in the urine sediment, protein rising on a quantitative test, or complement levels falling on a blood test. By the time swelling or a rise in blood pressure appears, the inflammation has usually been running for a while. This is why everyone with lupus has their urine checked at intervals even when they feel entirely well — the test is what finds the window in which treatment does the most.

Why does everyone with lupus nephritis need a kidney biopsy?

Because the treatment is chosen from what the microscope shows, and the same blood and urine results can come from several different lesions. The biopsy answers three questions no blood test can: which class this is, how much of what is there is active inflammation that will respond to immunosuppression, and how much is already scar and will not respond to anything. Those three answers set the intensity and the duration of treatment. Guessing from the urine is how people end up either under-treated — with avoidable scarring accumulating — or over-treated, carrying the risks of strong immunosuppression for a lesion that would never have responded to it.

How long does the treatment last?

Longer than most people expect, and in two clearly different phases. The first is induction: a few months of stronger treatment intended to stop the inflammation and bring the urine and blood tests back towards normal. The second is maintenance: years of gentler treatment at the lowest dose that holds the result. Maintenance is not a formality and it is not the same as being cured — stopping it early is one of the commonest reasons a remission is lost. Exactly how long depends on the class, on how complete the response was, and on what the rest of your lupus is doing, and your team should tell you the number they are working towards rather than leaving it open.

Can I stop treatment once I feel well again?

Not on your own, and not on the basis of feeling well. Feeling well is what treatment is supposed to produce, and it tells you nothing about whether the inflammation is quiet underneath — the urine sediment, the protein measurement, complement levels and anti-dsDNA are what answer that. Medicines are reduced on a schedule, after a defined period of stable results, and usually one at a time so that any change can be attributed to something. Stopping abruptly, particularly a glucocorticoid, carries its own risks. If a medicine is causing a problem worth stopping, that is a conversation to have rather than a decision to make alone.

Get the class read, and the whole picture assessed at once

Send your urine results with dates, your protein measurements, your creatinine and filtration readings if you have more than one, any complement and anti-dsDNA results, a biopsy report if you have one, and your current medicines including anything bought over the counter. Our team will return a written opinion on whether a biopsy would add information here, whether anything is missing from your workup, and which of the missing tests are worth doing before any travel is arranged.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*